NKGene Biotech IPO
Scope
Date
~
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
IPOs
Korean grocery delivery platform Oasis set for February IPO
South Korean grocery delivery platform Oasis Corp. aims to raise up to $166 million through a listing next month, becoming the country’s first...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
IPOs
S.Korea’s IPO market sours as Kurly postpones listing
South Korea’s initial public offering market has soured as gourmet food delivery platform Kurly Inc. delayed its listing amid deteriorating in...
Jan 04, 2023 (Gmt+09:00)
-
Chemical Industry
Solvay named preferred bidder to buy Solus Biotech
Belgian chemicals maker Solvay S.A. has been selected as the preferred bidder to acquire South Korean biomaterials maker Solus Biotech, according to...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotechs target US labs to speed up regulatory approval for tests
South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Private equity
BASF, ADM join race to buy Korean ceramide maker Solus Biotech
BASF SE, the world’s largest chemical producer, US food processing giant ADM Co. and two other global companies have joined the race to acquir...
Dec 27, 2022 (Gmt+09:00)
-
Venture capital
Korea’s big bio startups to launch $39 mn investment fund
South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023
An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
IPOs
Bionote slashs IPO price to 9,000 won, 50% lower than previous valuation
Everybody is aware that investment fever on biotech firms has already cooled due to rising interest rates and concerns over the fizzling economy, an...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech firm Noul signs MOU with disease center of Ghana
South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...
Dec 12, 2022 (Gmt+09:00)
-
IPOs
Naver affiliate Line Games seeks $756 million IPO in Korea
Line Games Corp., an affiliate of South Korea’s internet giant Naver Corp., plans to list its shares on the Korean stock market via an initial...
Dec 07, 2022 (Gmt+09:00)
-
Bio & Pharma
MDimune signs research agreement with Australian National University
MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...
Dec 07, 2022 (Gmt+09:00)
-
Korean startups
Korean unlisted stock bubble bursts as interest rates rise
Kurly Inc., Dunamu Inc. and other major South Korean unlisted stocks plunged as the fallout on asset prices from rising interest rates extended into...
Nov 30, 2022 (Gmt+09:00)
-
Korean stock market
Korea to reform market rules to boost foreign investment
South Korea will reform financial market regulations to attract more foreign investments and to achieve MSCI Inc.’s developed market status fo...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Chemical Industry
Samyang transitions to white biotech with S.Korea’s first isosorbide plant
Samyang Group, a diversified conglomerate, has long focused on the chemicals and foodstuffs sectors. While adding to its existing chemicals bus...
Nov 17, 2022 (Gmt+09:00)
-
IPOs
Miniforce producer aims to become Asia's top children's platform with IPO
The South Korean producer of famous animated series such as Miniforce aims to become Asia’s top children's platform by way of an initial publi...
Nov 15, 2022 (Gmt+09:00)
-
Korean games
Game design and development studio SHIFT UP eyes IPO
SHIFT UP Corp., known for its subculture games, is eyeing an initial public offering (IPO.) The game design and development studio confirmed th...
Nov 14, 2022 (Gmt+09:00)
-
IPOs
E-book platform Millie's Library drops IPO plan on tepid market interest
South Korean e-book platform Millie’s Library dropped its listing plan on Nov. 8 due to tepid demand from institutional investors, marking the...
Nov 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea’s Peak Bio makes Nasdaq debut via SPAC deal with Ignyte
Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...
Oct 28, 2022 (Gmt+09:00)
-
Pre-IPOs
Samsung SDI supplier Jaewon seeks about $280 mn in pre-IPO
South Korean mid-sized petrochemical company Jaewon Industrial Co. is looking to attract pre-IPO investment, according to investment banking sources...
Oct 19, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korea's LG Chem buys Nasdaq-listed biotech firm AVEO for $566 mn
South Korea’s chemicals giant LG Chem Ltd. announced on Oct. 18 that it will acquire AVEO Pharmaceuticals Inc., a Nasdaq-listed US biotech fir...
Oct 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio suffers as weak won lifts global clinical trial costs
South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...
Oct 14, 2022 (Gmt+09:00)
-
IPOs
Small caps warm up S.Korea’s chilly IPO market
Small and mid-sized companies are reviving the otherwise chilly IPO market in South Korea, which has been dragged down by weaker-than-expected deman...
Sep 29, 2022 (Gmt+09:00)